DE60000826T2 - 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene - Google Patents

14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Info

Publication number
DE60000826T2
DE60000826T2 DE60000826T DE60000826T DE60000826T2 DE 60000826 T2 DE60000826 T2 DE 60000826T2 DE 60000826 T DE60000826 T DE 60000826T DE 60000826 T DE60000826 T DE 60000826T DE 60000826 T2 DE60000826 T2 DE 60000826T2
Authority
DE
Germany
Prior art keywords
hydroxymethylandrostan
androgenes
beta
alpha
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60000826T
Other languages
English (en)
Other versions
DE60000826D1 (de
Inventor
Jan Loozen
Dirk Leysen
Der Louw Jaap Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE60000826D1 publication Critical patent/DE60000826D1/de
Application granted granted Critical
Publication of DE60000826T2 publication Critical patent/DE60000826T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60000826T 1999-03-08 2000-03-02 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene Expired - Lifetime DE60000826T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99200665 1999-03-08
PCT/EP2000/001755 WO2000053619A1 (en) 1999-03-08 2000-03-02 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens

Publications (2)

Publication Number Publication Date
DE60000826D1 DE60000826D1 (de) 2003-01-02
DE60000826T2 true DE60000826T2 (de) 2003-04-10

Family

ID=8239953

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60000826T Expired - Lifetime DE60000826T2 (de) 1999-03-08 2000-03-02 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Country Status (11)

Country Link
US (1) US6881728B1 (de)
EP (1) EP1163259B1 (de)
JP (1) JP4749550B2 (de)
AR (1) AR022852A1 (de)
AT (1) ATE228143T1 (de)
AU (1) AU3162200A (de)
CA (1) CA2359218A1 (de)
CO (1) CO5150195A1 (de)
DE (1) DE60000826T2 (de)
PE (1) PE20001489A1 (de)
WO (1) WO2000053619A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2258037T3 (es) * 1999-12-02 2006-08-16 Akzo Nobel N.V. Androgenos sustituidos con 14,15-beta-metilen.
US6949531B2 (en) * 2000-12-11 2005-09-27 Akzo Nobel N.V. 14 β, 16, 17-methylene steroids as novel androgens
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002746A (en) * 1959-09-25 1977-01-11 Herchel Smith Synthesis of gon-4-enes
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
US5264427A (en) 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception

Also Published As

Publication number Publication date
JP4749550B2 (ja) 2011-08-17
US6881728B1 (en) 2005-04-19
CA2359218A1 (en) 2000-09-14
JP2002539135A (ja) 2002-11-19
DE60000826D1 (de) 2003-01-02
PE20001489A1 (es) 2000-12-29
EP1163259B1 (de) 2002-11-20
CO5150195A1 (es) 2002-04-29
WO2000053619A1 (en) 2000-09-14
EP1163259A1 (de) 2001-12-19
AR022852A1 (es) 2002-09-04
ATE228143T1 (de) 2002-12-15
AU3162200A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
ATE228510T1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
ATE315036T1 (de) 2,4-diaminopyrimidinderivate als immunosuppressiva
MA26794A1 (fr) Derives de 5-phenyl-pyrimidine.
MA26793A1 (fr) Derives de 4-phenyl-pyrimidine.
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE60029755D1 (de) Congawandschutz.
DE60000826T2 (de) 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
IT1319526B1 (it) Macchina i.s.
IT1319528B1 (it) Macchina i.s.
NL1011488A1 (nl) Hoofdtelefoon-microfoon-combinatie.
ES1041748Y (es) Pantalon perfeccionado.
DE60017150D1 (de) 1,4,5,6 -tetrahydropyrimidine-derivative als vitronectin-hemmer
FR2790466B1 (fr) Machine i.s.
ES1044367Y (es) Piñata mejorada.
ES1043697Y (es) Contenedor-expositor perfeccionado.
ES1044451Y (es) Gavion perfeccionado.
ES1043296Y (es) Mosquero perfeccionado.
ITMI990856A1 (it) Composizione funghicida.
ES1044013Y (es) Nueva cantonera mejorada.
IT1313922B1 (it) Elettromandrino perfezionato.
ES1042809Y (es) Esponja-estropajo mejorado.
ES1043499Y (es) Tapa-soporte perfeccionada.
ES1044754Y (es) Acietera perfeccionada.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL

R082 Change of representative

Ref document number: 1163259

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE